Overactive Bladder in Children: Multimedia

References

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167-78. [Medline].

2. Bloom DA, Seeley WW, Ritchey ML, McGuire EJ. Toilet habits and continence in children: an opportunity sampling in search of normal parameters. J Urol. May 1993;149(5):1087-90. [Medline].

3. Kuh D, Cardozo L, Hardy R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidemiol Community Health. Aug 1999;53(8):453-8. [Medline].

4. Sureshkumar P, Craig JC, Roy LP, Knight JF. Daytime urinary incontinence in primary school children: a population-based survey. J Pediatr. Dec 2000;137(6):814-8. [Medline].

5. Järvelin MR, Vikeväinen-Tervonen L, Moilanen I, Huttunen NP. Enuresis in seven-year-old children. Acta Paediatr Scand. Jan 1988;77(1):148-53. [Medline].

6. Hellstrom AL, Hanson E, Hansson S, Hjalmas K, Jodal U. Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr. Mar 1990;149(6):434-7. [Medline].

7. Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Study of 1129 enuretis. Arch Dis Child. Apr 1974;49(4):259-63. [Medline].

8. Himsl KK, Hurwitz RS. Pediatric urinary incontinence. Urol Clin North Am. May 1991;18(2):283-93. [Medline].

9. Dator DP, Hatchett L, Dyro FM, Shefner JM, Bauer SB. Urodynamic dysfunction in walking myelodysplastic children. J Urol. Aug 1992;148(2 Pt 1):362-5. [Medline].

10. Peters CA, Bolkier M, Bauer SB, Hendren WH, Colodny AH, Mandell J, et al. The urodynamic consequences of posterior urethral valves. J Urol. Jul 1990;144(1):122-6. [Medline].

11. Lettgen B, von Gontard A, Olbing H, Heiken-Lowenau C, Gaebel E, Schmitz I. Urge incontinence and voiding postponement in children: somatic and psychosocial factors. Acta Paediatr. 2002;91(9):978-84; discussion 895-6. [Medline].

12. van Gool JD, de Jonge GA. Urge syndrome and urge incontinence. Arch Dis Child. Nov 1989;64(11):1629-34. [Medline].

13. Kuo HC. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity. Urology. Mar 2003;61(3):550-4. [Medline].

14. Hohenfellner M, Dahms SE, Matzel K, Thüroff JW. Sacral neuromodulation for treatment of lower urinary tract dysfunction. BJU Int. May 2000;85 Suppl 3:10-9; discussion 22-3. [Medline].

15. Klingler HC, Pycha A, Schmidbauer J, Marberger M. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology. Nov 1 2000;56(5):766-71. [Medline].

16. Sureshkumar P, Bower W, Craig JC, Knight JF. Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials. J Urol. Jul 2003;170(1):196-200; discussion 200. [Medline].

17. Youdim K, Kogan BA. Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology. Mar 2002;59(3):428-32. [Medline].

18. Palmer LS, Zebold K, Firlit CF, Kaplan WE. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population. J Urol. Feb 1997;157(2):638-40. [Medline].

19. Ferrara P, D'Aleo CM, Tarquini E, Salvatore S, Salvaggio E. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. BJU Int. May 2001;87(7):674-8. [Medline].

20. Hjälmås K, Hellström AL, Mogren K, Läckgren G, Stenberg A. The overactive bladder in children: a potential future indication for tolterodine. BJU Int. Apr 2001;87(6):569-74. [Medline].

21. Lopez Pereira P, Miguelez C, Caffarati J, Estornell F, Anguera A. Trospium chloride for the treatment of detrusor instability in children. J Urol. Nov 2003;170(5):1978-81. [Medline].

22. Kjølseth D, Madsen B, Knudsen LM, Nørgaard JP, Djurhuus JC. Biofeedback treatment of children and adults with idiopathic detrusor instability. Scand J Urol Nephrol. Sep 1994;28(3):243-7. [Medline].

23. Curran MJ, Kaefer M, Peters C, Logigian E, Bauer SB. The overactive bladder in childhood: long-term results with conservative management. J Urol. Feb 2000;163(2):574-7. [Medline].

24. Cvitkovic-Kuzmic A, Brkljacic B, Ivankovic D, Grga A. Ultrasound assessment of detrusor muscle thickness in children with non-neuropathic bladder/sphincter dysfunction. Eur Urol. Feb 2002;41(2):214-8; discussion 218-9. [Medline].

25. Franco I. Overactive bladder in children. Part 1: Pathophysiology. J Urol. Sep 2007;178(3 Pt 1):761-8; discussion 768. [Medline].

26. Franco I. Overactive bladder in children. Part 2: Management. J Urol. Sep 2007;178(3 Pt 1):769-74; discussion 774. [Medline].

27. Müller L, Bergström T, Hellström M, Svensson E, Jacobsson B. Standardized ultrasound method for assessing detrusor muscle thickness in children. J Urol. Jul 2000;164(1):134-8. [Medline].

Further Reading

For additional information, see Medscape’s Urinary Incontinence & OAB Resource Center.

Keywords

overactive bladder, pediatric overactive bladder, overactive bladder in children, idiopathic overactive bladder, idiopathic OAB, urge syndrome, unstable bladder, detrusor overactivity, detrusor overactivity of a neurogenic etiology, neurogenic detrusor overactivity, OAB, dysfunctional voiding, voiding postponement, urinary urgency, urgency urinary incontinence, urinary frequency, nocturia, Vincent curtsy sign, Vincent’s curtsy, Vincent curtsey, Vincent’s curtsey, pelvic floor muscles, cerebral palsy, spinal cord injury, sacral agenesis, imperforate anus, posterior urethral valves, neuromodulation, urinary tract infection, UTI, bladder augmentation, bladder autoaugmentation, oxybutynin, Ditropan XL

Contributor Information and Disclosures

Author

Pamela I Ellsworth, MD, FACS, Associate Professor of Urology, Brown University; Consulting Staff, University Urological Associates
Pamela I Ellsworth, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Urological Association, Phi Beta Kappa, Society for Fetal Urology, and Society of University Urologists
Disclosure: Pfizer Consulting fee Consulting; Novartis Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Allergan Honoraria Speaking and teaching

Coauthor(s)

Katherine M Callaghan, University of Massachusetts Medical School
Disclosure: Nothing to disclose.

Medical Editor

Gamal Mostafa Ghoniem, MD, FACS, Fellowship Program Director, Clinical Professor of Surgery, Head, Section of Voiding Dysfunction, Female Urology and Reconstruction, Cleveland Clinic Florida
Gamal Mostafa Ghoniem, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urogynecologic Society, American Urological Association, Florida Medical Association, International Continence Society, and International Urogynaecology Association
Disclosure: Astellas Honoraria Speaking and teaching; Coloplasty Consulting fee Consulting; Uroplasty Consulting fee Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Gyrus-ACMI Honoraria Speaking and teaching

Chief Editor

Edward David Kim, MD, FACS, Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center
Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, and Tennessee Medical Association
Disclosure: Lilly Consulting fee Consulting; Astellas Consulting fee Speaking and teaching; Indevus Consulting fee Speaking and teaching